Updates are available Correction dated 2025-01-06

Article History

Received: 8 February 2022

Accepted: 12 October 2022

First Online: 24 October 2022

Change Date: 6 January 2025

Change Type: Update

Change Details: The original online version of this article was revised: In the competing interest section, the following information has been added: Author AH is a member of the editorial board for Journal of Cannabis Research. Author AH was not involved in the journal’s review of, or decisions related to this manuscript.

Change Date: 6 January 2025

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s42238-024-00254-8

Declarations

:

: Not applicable. No human or animal data was utilized during this study.

: All authors have consented to publication of this manuscript. No individual personal/private data is incorporated in this report.

: Joshua Aviram, Daniella Atzmony, Asaf Kroll, Anna Frenklakh, and Ilana Zaks were employed by Syqe Medical Ltd. at the time the paper was written. Arno Hazekamp was an external hired consultant to Syqe Medical Ltd. at the time the paper was written. Syqe Medical Ltd. collected samples and provided them to an external laboratory as required by local regulations for independent analyses. The authors then drafted this document based on the independent laboratory’s reports. Joshua Aviram, the Clinical Research Director in Syqe Medical Ltd., performed the statistical analysis of the data, prepared the first draft of the manuscript, and made the decision to publish. All authors reviewed the final version of the manuscript. Author AH is a member of the editorial board for Journal of Cannabis Research. Author AH was not involved in the journal’s review of, or decisions related to this manuscript.